Multiple acyl-CoA dehydrogenase deficiency (MADD): clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Multiple acyl-CoA dehydrogenase deficiency (MADD): clinical features. MADD is caused by mutations in the electronic transfer flavoprotein (ETF) gene.
Genetics
- MADD is caused by mutations in the electronic transfer flavoprotein (ETF) gene
- ETFDH causes riboflavin-responsive MADD (RR-MADD)
- The transmission is autosomal recessive
Pathogenesis
Locked: subscribe to see this section.
Types
Locked: subscribe to see this section.
Acquired causes
Locked: subscribe to see this section.
Muscle features
Locked: subscribe to see this section.
Systemic features
Locked: subscribe to see this section.
Features in crises
Locked: subscribe to see this section.
Other features
Locked: subscribe to see this section.
Differential diagnosis
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Olsen RK, Olpin SE, Andresen BS, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007; 130:2045-2054.
- Liang WC, Nishino I. Lipid storage myopathy. Curr Neurol Neurosci Rep 2011; 11:97-103.
- Mumtaz HA, Gupta V, Singh P, Marwaha RK, Khandelwal N. MR imaging findings of glutaric aciduria type II. Singapore Med J 2010; 51:e69-e71.
- Pollard LM, Williams NR, Espinoza L, et al. Diagnosis, treatment, and long-term outcomes of late-onset (type III) multiple acyl-CoA dehydrogenase deficiency. J Child Neurol 2010; 25:954-960.
- van der Westhuizen FH, Smuts I, Honey E, et al. A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency. J Neurol Sci 2018; 384:121-125.
- And 19 more. Subscribe to see the full list
